Please login to the form below

Not currently logged in
Email:
Password:

London Genetics senior appointments

London Genetics has made three appointments to its board and management team

London Genetics, which expedites pharmacogenetic partnerships between the biopharmaceutical industry and London-based centres of genetics research, has made three appointments to its board and management team.

Dr Barrie Ward has been appointed as chairman to drive the next phase of the company's growth as the importance of pharmacogenetics in drug development increases. He previously held senior positions at GSK R&D and various biotechnology companies in the US and UK.

In addition, Dominique Kleyn has been brought on as CEO and Dr Mark Caulfield has been appointed clinical director. Kleyn previously held leadership roles at Imperial College London and within the biotech sector; Caulfield is an expert in the genetics of cardiovascular disease, particularly hypertension. He is director of the William Harvey Research Institute at Bart's and the London School of Medicine and Dentistry at Queen Mary, University of London.

Commenting on his appointment, Dr Ward said: "I am delighted to have joined the strong team at London Genetics at a time when the importance of pharmacogenetics in drug development is becoming increasingly clear. This is a pivotal phase of the company's development as it works in partnership with biopharmaceutical companies to add value to drug development programmes."

Ms Kleyn added: "We have an exciting partnering programme lined up for the coming months and I look forward to working together with our founding institutions and the biopharmaceutical industry to build interactions that will help to make a difference to drug development."

London Genetics has broad therapeutic experience with a particular focus on cardiovascular drugs and cardiovascular safety.

22nd September 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Spotlight interview: 15 minutes on insights and market research in pharma
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma...
WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....

Infographics